SMAC mimetics are therefore used in combination with drugs that stimulate the extrinsic (e.g. TRAIL, TNFα) or the intrinsic (e.g. chemotherapeutics) apoptotic pathways to enhance cancer cell death (36, 37). The gene discussed is TNF; the disease is cancer.